Docebo (DCBO) Competitors

$44.72
+0.72 (+1.64%)
(As of 04/26/2024 ET)

DCBO vs. OPRA, VTEX, SOUN, EVBG, ZUO, PDFS, BASE, ENFN, BB, and EVCM

Should you be buying Docebo stock or one of its competitors? The main competitors of Docebo include Opera (OPRA), VTEX (VTEX), SoundHound AI (SOUN), Everbridge (EVBG), Zuora (ZUO), PDF Solutions (PDFS), Couchbase (BASE), Enfusion (ENFN), BlackBerry (BB), and EverCommerce (EVCM). These companies are all part of the "prepackaged software" industry.

Docebo vs.

Docebo (NASDAQ:DCBO) and Opera (NASDAQ:OPRA) are both small-cap computer and technology companies, but which is the superior investment? We will contrast the two companies based on the strength of their profitability, dividends, institutional ownership, earnings, analyst recommendations, risk, valuation, community ranking and media sentiment.

Opera has higher revenue and earnings than Docebo. Opera is trading at a lower price-to-earnings ratio than Docebo, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Docebo$180.84M7.48$2.84M$0.09494.94
Opera$396.83M2.94$169.41M$1.886.98

Opera received 66 more outperform votes than Docebo when rated by MarketBeat users. However, 65.22% of users gave Docebo an outperform vote while only 58.73% of users gave Opera an outperform vote.

CompanyUnderperformOutperform
DoceboOutperform Votes
45
65.22%
Underperform Votes
24
34.78%
OperaOutperform Votes
111
58.73%
Underperform Votes
78
41.27%

In the previous week, Opera had 58 more articles in the media than Docebo. MarketBeat recorded 67 mentions for Opera and 9 mentions for Docebo. Docebo's average media sentiment score of 0.61 beat Opera's score of 0.07 indicating that Docebo is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Docebo
2 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
2 Negative mention(s)
0 Very Negative mention(s)
Positive
Opera
5 Very Positive mention(s)
7 Positive mention(s)
41 Neutral mention(s)
7 Negative mention(s)
1 Very Negative mention(s)
Neutral

Docebo has a beta of 1.64, indicating that its stock price is 64% more volatile than the S&P 500. Comparatively, Opera has a beta of 0.81, indicating that its stock price is 19% less volatile than the S&P 500.

53.2% of Docebo shares are owned by institutional investors. Comparatively, 10.2% of Opera shares are owned by institutional investors. 84.4% of Opera shares are owned by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock is poised for long-term growth.

Opera has a net margin of 42.69% compared to Docebo's net margin of 1.57%. Opera's return on equity of 19.90% beat Docebo's return on equity.

Company Net Margins Return on Equity Return on Assets
Docebo1.57% 12.45% 6.57%
Opera 42.69%19.90%18.08%

Docebo currently has a consensus price target of $61.40, suggesting a potential upside of 38.35%. Opera has a consensus price target of $21.17, suggesting a potential upside of 62.32%. Given Opera's stronger consensus rating and higher probable upside, analysts clearly believe Opera is more favorable than Docebo.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Docebo
0 Sell rating(s)
1 Hold rating(s)
10 Buy rating(s)
0 Strong Buy rating(s)
2.91
Opera
0 Sell rating(s)
0 Hold rating(s)
2 Buy rating(s)
0 Strong Buy rating(s)
3.00

Summary

Opera beats Docebo on 11 of the 18 factors compared between the two stocks.

Get Docebo News Delivered to You Automatically

Sign up to receive the latest news and ratings for DCBO and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding DCBO and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

DCBO vs. The Competition

MetricDoceboPrepackaged software IndustryComputer SectorNASDAQ Exchange
Market Cap$1.35B$21.43B$17.84B$7.63B
Dividend YieldN/A2.17%2.74%3.93%
P/E Ratio494.94100.59232.8616.45
Price / Sales7.489.28524.4981.82
Price / Cash74.0465.6827.7535.09
Price / Book26.679.606.614.39
Net Income$2.84M$372.81M$564.94M$213.88M
7 Day Performance0.11%4.60%2.64%1.82%
1 Month Performance-10.63%-1.55%-2.09%-3.77%
1 Year Performance22.56%21.50%17.04%9.28%

Docebo Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
OPRA
Opera
4.3113 of 5 stars
$15.03
+2.5%
$21.17
+40.8%
+20.9%$1.33B$396.83M7.99606Earnings Report
VTEX
VTEX
2.5077 of 5 stars
$7.44
-0.5%
$8.44
+13.4%
+115.9%$1.37B$201.52M-106.271,277Short Interest ↓
SOUN
SoundHound AI
3.1794 of 5 stars
$4.06
+2.3%
$6.88
+69.5%
+84.1%$1.25B$45.87M-10.41260Gap Down
EVBG
Everbridge
3.9416 of 5 stars
$34.87
+0.0%
$29.00
-16.8%
+32.3%$1.45B$448.79M-24.381,593Short Interest ↓
Positive News
ZUO
Zuora
1.4832 of 5 stars
$8.47
+1.2%
$12.00
+41.7%
+24.0%$1.24B$431.66M-17.651,618
PDFS
PDF Solutions
4.0841 of 5 stars
$31.93
+0.9%
$46.00
+44.1%
-19.6%$1.23B$165.84M456.14493
BASE
Couchbase
3.5109 of 5 stars
$24.35
+1.4%
$32.40
+33.1%
+59.6%$1.20B$180.04M-14.32796Short Interest ↑
ENFN
Enfusion
1.3953 of 5 stars
$9.27
+1.2%
$9.33
+0.7%
+13.1%$1.19B$174.54M115.831,102Positive News
BB
BlackBerry
2.3001 of 5 stars
$2.72
-1.4%
$4.08
+50.1%
-30.0%$1.60B$853M-11.332,647Short Interest ↓
EVCM
EverCommerce
2.1154 of 5 stars
$8.63
+0.5%
$11.13
+28.9%
-26.6%$1.61B$675.37M-37.522,100Short Interest ↑

Related Companies and Tools

This page (NASDAQ:DCBO) was last updated on 4/26/2024 by MarketBeat.com Staff

From Our Partners